“Tratamento farmacológico da depressão na infância e na adolescência” – Prof. Christian Kieling
HIGHLIGHTS MASTERCLASS DE ATUALIZAÇÃO TERAPÊUTICA (2024)!!!
TEMA: “Desvendando as peculiaridades do tratamento farmacológico da depressão na infância e na adolescência” – PROF. CHRISTIAN KIELING
TÓPICOS ABORDADOS NESTE HIGHLIGHT:
– Diferenças entre os principais guidelines;
– “Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis;
– “Comparing apples and oranges in youth depression treatments? A quantitative critique of the evidence base and guidelines”;
– Psicoterapias: evidências de eficácia;
– “The Psychopharmacology of Adolescent Depression”;
– “Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial”;
– “Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)”;
– “Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: The TORDIA Randomized Controlled Trial”;
– Uso de antidepressivos em crianças e adolescentes: recomendações.
TÓPICOS DA AULA NA ÍNTEGRA: (DISPONÍVEL NO PORTAL https://masterclasspsiquiatria.com.br/)
– “Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019”;
– Burden of depressive disorders in terms of total disability-adjusted life-years (DALYs) across the lifespan;
– “Worldwide Prevalence and Disability From Mental Disorders Across Childhood and Adolescence: Evidence From the Global Burden of Disease Study”;
– Ranking of Mental Disorders and Substance Use Disorders According to Nonfatal Disability Expressed as Years Lived With Disability (YLDs) by Age Group, Both Sexes Combined;
– Proportion of Years Lived With Disability (YLDs) According to Age Group and Sex for Mental Disorders, Cardiovascular Disease, and Diabetes, Neoplasms, and Unintentional Injuries;
– Global Prevalence of Mental Disorders by Sex and Age Group From Age 5 to 24 Years;
– Depressão em crianças e adolescentes: particularidades da avaliação diagnóstica;
– “Sistema de posicionamento mental”;
– Mood and Feelings Questionnaire;
– “Translation and cross-cultural adaptation into Brazilian Portuguese of the Mood and Feelings Questionnaire (MFQ) – Long Version”;
– Children’s Depression Rating Scale – Revised (CDRS-R);
– Fenotipagem digital;
– “Improving clinical decision-making in psychiatry: implementation of digital phenotyping could mitigate the influence of patient’s and practitioner’s individual cognitive biases”;
– “Grumpy or depressed? Disentangling typically developing adolescent mood from prodromal depression using experience sampling methods”;
– “Assessing Mood With the Identifying Depression Early in Adolescence Chatobot (IDEABot): Development and Implementation Study”;
– “A meta-analysis of correlations between depression and first person singular pronoun use”;
– “Prospective Follow-Up of Adolescents With and at Risk for Depression: Protocol and Methods of the Identifying Depression Early in Adolescence Risk Stratified Cohort Longitudinal Assessments”;
– Avaliação longitudinal, avaliação de riscos, psicoeducação e planejamento terapêutico;
– “Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies”;
– “Antidepressant Use and Risk of Manic Episodes in Children and Adolescents With Unipolar Depression”;
– “Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials”;
– “Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study”;
– “Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries”;
– “Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial”;
– “Thinking about Prescribing: The Psychology of Psychopharmacology with Diverse Youth and Families”;
– “The Lancet Psychiatry Commission on youth mental health”.